Pabak Mukhopadhyay, Ph.D., is an experienced professional in the field of biostatistics and oncology, currently serving as the Executive Director of Late Oncology Statistics and Head of Breast Cancer Strategy at AstraZeneca. Previous roles include Executive Director of Biostatistics at Daiichi Sankyo, Inc., and Senior Director of Biostatistics at Novartis Oncology. Pabak Mukhopadhyay started a career at Schering-Plough Research Institute, where responsibilities ranged from Senior Research Statistician to Project Leader. Pabak Mukhopadhyay earned a Ph.D. in Statistics from North Carolina State University between 1996 and 2000.